Podcast: Download (Duration: 1:04 — 1.5MB)
Subscribe: RSS
Anchor lead: Can a mixture of antibodies help our bodies respond to Sars-CoV2? Elizabeth Tracey reports Engineered viruses form the backbone of a few of the Covid-19 vaccines being used and tested around the world, and these vaccines stimulate our …
Podcast: Download (Duration: 1:03 — 1.4MB)
Subscribe: RSS
Anchor lead: Could some vaccines prompt a broader immune response? Elizabeth Tracey reports Sars-CoV2 vaccines all attempt to stimulate the body to produce antibodies against the virus’s spike protein, used to infect our cells. Yet Andrew Pekosz, a vaccine expert …
Podcast: Download (Duration: 1:05 — 1.5MB)
Subscribe: RSS
Anchor lead: There are still many steps to getting a Covid-19 vaccine to market, Elizabeth Tracey reports At least three vaccines against Sars-CoV2 are in later stage clinical trials domestically, with another just entering this phase. Andrew Pekosz, a vaccine …
Podcast: Download (Duration: 1:04 — 1.5MB)
Subscribe: RSS
Anchor lead: Can a mailed in screening test for colon cancer work? Elizabeth Tracey reports Sending people colon cancer screening kits where they can simply send in a fecal sample they collect themselves at home is cost effective and acceptable, …
Podcast: Download (Duration: 1:03 — 1.4MB)
Subscribe: RSS
Anchor lead: Among those with cancer, Covid infection affects those with leukemia most, Elizabeth Tracey reports If you have leukemia, you may be at high risk for severe Covid-19 disease, a recent study found. Yet William Nelson, director of the …
Podcast: Download (Duration: 1:05 — 1.5MB)
Subscribe: RSS
Anchor lead: A new targeted agent in certain cancers proves very beneficial, Elizabeth Tracey reports People with a mutation in their cancers abbreviated RET may benefit from an agent called selpercatinib, two studies in the New England Journal of Medicine report. …
